Real-World Treatment Duration Of Subsequent Therapy After Palbociclib (Pal) In Patients With Hormone Receptor-Positive (Hr+)/Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc) In Japan
Palbociclib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Real-World Treatment Duration Of Subsequent Therapy After Palbociclib (Pal) In Patients With Hormone Receptor-Positive (Hr+)/Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc) In Japan ### Output: Palbociclib